Suppr超能文献

心脏再生中的间充质干细胞:过去6年(2010 - 2015年)的详细进展报告

Mesenchymal stem cells in cardiac regeneration: a detailed progress report of the last 6 years (2010-2015).

作者信息

Singh Aastha, Singh Abhishek, Sen Dwaipayan

机构信息

School of Bio Sciences and Technology, VIT University, Vellore, India.

Cellular and Molecular Therapeutics Laboratory, Centre for Biomaterials, Cellular and Molecular Theranostics (CBCMT), VIT University, Vellore, 632014, Tamil Nadu, India.

出版信息

Stem Cell Res Ther. 2016 Jun 4;7(1):82. doi: 10.1186/s13287-016-0341-0.

Abstract

Mesenchymal stem cells have been used for cardiovascular regenerative therapy for decades. These cells have been established as one of the potential therapeutic agents, following several tests in animal models and clinical trials. In the process, various sources of mesenchymal stem cells have been identified which help in cardiac regeneration by either revitalizing the cardiac stem cells or revascularizing the arteries and veins of the heart. Although mesenchymal cell therapy has achieved considerable admiration, some challenges still remain that need to be overcome in order to establish it as a successful technique. This in-depth review is an attempt to summarize the major sources of mesenchymal stem cells involved in myocardial regeneration, the significant mechanisms involved in the process with a focus on studies (human and animal) conducted in the last 6 years and the challenges that remain to be addressed.

摘要

几十年来,间充质干细胞一直被用于心血管再生治疗。在动物模型和临床试验中经过多次测试后,这些细胞已被确立为潜在的治疗剂之一。在此过程中,已确定了间充质干细胞的各种来源,这些来源通过激活心脏干细胞或使心脏的动脉和静脉血管再生来帮助心脏再生。尽管间充质细胞疗法备受赞誉,但仍存在一些挑战,要将其确立为一项成功的技术,这些挑战仍需克服。本深入综述旨在总结参与心肌再生的间充质干细胞的主要来源、该过程中涉及的重要机制,重点关注过去6年进行的(人类和动物)研究以及有待解决的挑战。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eeac/4893234/fbc1d310ff42/13287_2016_341_Fig1_HTML.jpg

相似文献

1
2
Mechanistic effects of mesenchymal and hematopoietic stem cells: New therapeutic targets in myocardial infarction.
J Cell Biochem. 2018 Jul;119(7):5274-5286. doi: 10.1002/jcb.26637. Epub 2018 Mar 12.
3
Mesenchymal stem cell therapy: A promising cell-based therapy for treatment of myocardial infarction.
J Gene Med. 2017 Dec;19(12). doi: 10.1002/jgm.2995. Epub 2017 Dec 8.
5
Transplantation of Simian Mesenchymal Stem Cells to Baboons with Experimentally Induced Myocardial Infarction.
Bull Exp Biol Med. 2016 Feb;160(4):589-91. doi: 10.1007/s10517-016-3223-7. Epub 2016 Feb 24.
8
Mesenchymal stem cell delivery strategies to promote cardiac regeneration following ischemic injury.
Biomaterials. 2014 Apr;35(13):3956-74. doi: 10.1016/j.biomaterials.2014.01.075. Epub 2014 Feb 21.
9
Emerging Role of Stem Cells - Derived Exosomes as Valuable Tools for Cardiovascular Therapy.
Curr Stem Cell Res Ther. 2017;12(2):134-138. doi: 10.2174/1574888X10666151026115320.

引用本文的文献

1
Cardiac transplantation: A review of current status and emerging innovations.
World J Transplant. 2025 Jun 18;15(2):100460. doi: 10.5500/wjt.v15.i2.100460.
2
Precise nanoscale fabrication technologies, the "last mile" of medicinal development.
Acta Pharm Sin B. 2025 May;15(5):2372-2401. doi: 10.1016/j.apsb.2025.03.040. Epub 2025 Mar 18.
3
Transcription Factor SOX10 Improves Migration and Homing of MSCs After Myocardial Infarction by Upregulating CXCR4.
Stem Cells Int. 2025 May 26;2025:1880402. doi: 10.1155/sci/1880402. eCollection 2025.
5
Extracellular Vesicles from Adipose Tissue-Derived Stromal Cells Stimulate Angiogenesis in a Scaffold-Dependent Fashion.
Tissue Eng Regen Med. 2024 Aug;21(6):881-895. doi: 10.1007/s13770-024-00650-4. Epub 2024 Jul 8.
6
Mesenchymal stem cell secretome for regenerative medicine: Where do we stand?
J Adv Res. 2025 Apr;70:103-124. doi: 10.1016/j.jare.2024.05.004. Epub 2024 May 9.
8
Regenerative Medicine and Nanotechnology Approaches against Cardiovascular Diseases: Recent Advances and Future Prospective.
Curr Stem Cell Res Ther. 2025;20(1):50-71. doi: 10.2174/011574888X263530230921074827.
9
Application of adipose-derived stem cells in ischemic heart disease: theory, potency, and advantage.
Front Cardiovasc Med. 2024 Jan 19;11:1324447. doi: 10.3389/fcvm.2024.1324447. eCollection 2024.
10
Immunomodulatory differences between mesenchymal stem cells from different oral tissues.
Heliyon. 2023 Dec 13;10(1):e23317. doi: 10.1016/j.heliyon.2023.e23317. eCollection 2024 Jan 15.

本文引用的文献

1
MicroRNAs as a diagnostic tool for heart failure and atrial fibrillation.
Curr Opin Pharmacol. 2016 Apr;27:24-30. doi: 10.1016/j.coph.2016.01.001. Epub 2016 Feb 4.
5
Mesenchymal Stem Cells and Cardiomyocytes Interplay to Prevent Myocardial Hypertrophy.
Stem Cells Transl Med. 2015 Dec;4(12):1425-35. doi: 10.5966/sctm.2015-0032. Epub 2015 Nov 19.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验